SUGAR LAND, TX / ACCESSWIRE / June 3, 2020 / With its new Houston production facility up and running and with a Texas hemp-handling license in hand, Neutra Corp. (OTC PINK:NTRR) stands ready to take full advantage of the American public’s growing appetite for quality CBD products. Many experts are predicted this market will increase an annual average of 107 percent and shortly reach a size of $22 billion in the U.S.
“We are exactly where we need to be at this point,” said Neutra CEO Sydney Jim. “Our long-range planning has us set up for long-term success. We’ve had a great run over the past year and we’re now in a position to make that planning and hard work pay off. To our investors, I say thank you for your patience.”
Most recently, Neutra announced it had retired the last of its convertible debt with one of two of its last lenders. This gives the company more freedom of movement and greater flexibility. It’s also a sign of financial stability.
With a Texas hemp-handling license, VIVIS Corp, Neutra’s wholly owned subsidiary has many strategic sources where it can obtain compliant hemp biomass for its growing range of CBD products. The company’s Houston production facility is now up and running. With this facility online, VIVIS is able to produce compliant, full-spectrum distillate, broad-spectrum distillate, 99%+ crystalline cannabidiol (Isolate). The company is also able to manufacture a wide range of end-user CBD products, such as tinctures, gummies, lotions, salves, etc.
VIVIS Corporation’s product line also gives Neutra a retail marketing foothold to get its products to the buying public. VIVIS is a respected brand in the marketplace known for its lab-tested quality. http://viviscbd.com
With VIVIS production facility coming online, it focuses on making sure it takes the right steps to ensure we can take on big box orders. There is still an open communication with the Power Auto Group for its expansion to Florida, but the focus is on VIVIS’ flagship facility in Houston, Texas first.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.neutrainc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp.
View source version on accesswire.com:
https://www.accesswire.com/592579/Neutra-Well-Positioned-for-Future-Growth-in-Booming-Hemp-Based-CBD-Market
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…